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Forgoing care because of costs is a frequent situation in many countries, with estimated 
prevalences going from 4% to 30% [1-6]. It can be defined as a decision of not seeking 
care when needed because of financial reasons and the term is used interchangeably 
with unmet needs as both terms provide similar information [7]. Whereas most studies 
on the prevalence of forgoing care because of costs target the general populations, little 
is known of the prevalence of forgoing care for people with specific chronic conditions. 
The few studies exploring this issue reported a prevalence close to general population 
figures [5, 8-9]. As people with chronic conditions have a high demand of health care, 
such prevalence may either be lower, since they are being followed by a health 
practitioner and are already navigating the system, or on the contrary, may be similar or 
higher, since they might decide to prioritize some health issues at the expense of other 
conditions.   
Our main objective was to assess the prevalence of forgoing care because of costs in 
Swiss patients with diabetes; a secondary objective was to explore whether forgoing 
care because of costs was related to a risk of worsening the quality of their care after 
three years of follow-up.  
We used data from a prospective Swiss cohort study, the CoDiab-VD cohort, consisting 
of non-institutionalized adults with a diagnosis of diabetes of at least one-year duration 
and residing in the canton of Vaud (≈ 750’000 inhabitants). Participants were recruited in 
2011-2012 by community-based pharmacies and are followed-up yearly [10]. Study 
data were collected from paper-based questionnaires sent to participants’ home. All 
variables, described in details elsewhere [10], are briefly presented thereafter. The 
primary exposure variable of the study was forgoing care because of costs at baseline, 
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measured using the following question: “During the last twelve months, did you forgo 
any type of care because of the costs you would have to pay?” Participants were 
considered to have forgone care during the past 12 months if they answered “yes” to 
that question. We considered eight diabetes-specific processes of care (e.g. HbA1c 
control, annual foot examination) and five outcomes of care (e.g. mean HbA1c, generic 
and disease-specific health-related quality of life) as dependent variables, and other 
covariates (e.g. age, gender, socio-demographics) [10]. The prevalence (and 95% 
confidence interval) of forgoing care and the type of care forgone were calculated. 
Then, bivariate analyses were conducted to compare participants forgoing vs not 
forgoing care. Finally, crude and adjusted mixed logistic and linear regression models 
were used to assess the over time effect of forgoing care on the dichotomous and 
continuous processes and outcomes of care indicators, respectively. 
At baseline, results showed a prevalence of persons reporting having forgone care 
because of costs of 15.7% (95% CI 12.5%-18.9%), with dental (9.7%) and foot (5.2%) 
care most often reported to have been forgone (other types of care forgone being each 
reported by less than 2% of the participants). Table 1 summarizes characteristics of all 
519 baseline participants, globally and according to their forgoing care status. People 
having forgone care were more likely to be women, non-Swiss, to receive health 
insurance subsidies, in poorer subjective health, report more co-morbidities, and be 
inactive; they also visited as many healthcare professionals and as often as the people 
not forgoing care, were more likely to have been hospitalized or have had 
emergency/non-scheduled visits during the past twelve months, yet more likely to have 
participated in education classes. 
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Primary and secondary baseline processes and outcomes of care results, according to 
the forgoing care status (Table 1) show that there were no statistically significant 
differences between the two groups, except for (health-related) quality of life which 
appeared significantly worse for persons forgoing care. Longitudinal analyses did not 
show a significant impact on the evolution of the quality of care patients with diabetes 
forgoing care, after three years (data not shown). 
The prevalence of forgoing care among patients with diabetes was similar to that of the 
general Swiss population, situated at around 15% in 2013 for respondents declaring 
one or more chronic condition [1]. Moreover, the socio-demographics, household 
income and subjective health of this study’s participants reporting forgoing care 
because of costs were similar to previous studies not targeting specifically persons with 
diabetes [6]. Whereas participants who declared forgoing care at baseline, reported 
suggestive evidence of high healthcare utilization and worse (health-related) quality of 
life, compared to participants not forgoing care, the three-year evolution over time did 
not seem to impact the medium-term quality of care of these persons, even when 
considering potential confounding variables. The somewhat paradoxical reports of 
forgoing care because of costs yet over-utilization of other types of care (emergency 
visits) could be explained by the reimbursement of certain care and not of others (i.e. 
dental and podiatric care) with the overall compensatory effect that the three-year 
quality of care had not worsened or that the power of the study was not enough to 
detect an effect. 
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This study showed that forgoing care because of costs concerned approximately one 
out of six persons living with diabetes. Although it did not show an impact on the quality 
of care of those patients in a three-year period, this should not lead to an 
underestimation of the potential risk to the health of people forgoing care. Healthcare 
practitioners should be aware of that issue and investigate what types of care are 
forgone and how to minimize them. Further examination of how health and care of 
people with chronic conditions, who declare forgoing care, evolves in the long run, 
should be carried out. It should also assess what the corresponding patient-reported 
unmet need is and whether it is recognized by the practitioner. People forgoing care 
because of costs are less well off than those not forgoing care and need stronger 
support to maintain stable overall health and quality of care. Healthcare systems, in 
Switzerland and elsewhere, should therefore strive to reduce the percentage of people 
forgoing care because of costs to a minimum.   
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Table 1: Baseline characteristics, healthcare utilization and quality of care of 
persons with diabetes, according to forgoing care status 
 
   
All 
participants 
* 
 
Participants 
forgoing care 
 
 
Participants 
not forgoing 
care 
 
P-
values 
  (n=519) (n=79) (n=424)  
      
Socio-demographics 
 
     
Age, mean (SD) (n=519) 64.5 (11.3) 61.8 (13.2) 64.9 (10.8) 0.02 
Women (n=519) 40.3% 50.6% 37.5% 0.03 
Living alone at home (n=516) 26.7% 36.7% 24.2% 0.02 
Education (n=504)    0.19 
  Primary  18.9% 24.7% 17.0%  
  Secondary  56.2% 55.8% 56.6%  
  Tertiary  25.0% 19.5% 26.5%  
Health insurance subsidies (n=515) 16.3% 26.6% 14.0% 0.01 
Nationality (n=515)     
  Swiss  88.2% 82% 89.3% 0.05 
 
Health status 
 
    
     
Subjective health (n=509)    0.00 
  Excellent/very good  14.2% 5.1% 16.4%  
  Good  64.2% 56.4% 65.1%  
  Mediocre/bad  21.6% 38.5% 18.5%  
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Screen-positive for 
depression 
(n=503) 30.6% 56.6% 26.1% 0.00 
Current smoking (n=509) 17.3% 19.5% 17.0% 0.62 
Physical inactivity 
 
(n=494) 29.8% 44.2% 26.2% 0.00 
      
Diabetes characteristics 
 
     
Type 2 diabetes (n=519) 84.6% 79.7% 85.6% 0.18 
Diabetes duration (n=511)    0.22 
 < 10 years  52.1% 46.2% 54.2%  
  >10 years  47.9% 53.8% 45.8%  
Diabetes treatment                
(oral-anti-diabetic drugs) 
(n=516) 50.8% 44.9% 52.2% 0.27 
Diabetes complications †, 
mean (SD) 
(n=504) 0.7 (1) 0.9 (1) 0.7 (0.9) 0.20 
      
      
Healthcare utilization      
GP visits (past 12 m) (n=473)    0.09 
0  6.3% 8.8% 6.1%  
1  12.9% 8.8% 13.7%  
2-3  38.3% 27.9% 39.6%  
≥4  42.5% 54.4% 40.6%  
Diabetologist visits (past 
12m) 
(n=334)    0.28 
0  35.6% 25.5% 38.4%  
1  12.3% 14.5% 12.2%  
2-3  28.7% 30.9% 28.0%  
≥4  23.4% 29.1% 21.4%  
Hospitalization (past 12 m) (n=506) 26.5% 37.7% 24.2% 0.02 
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Emergency/unscheduled 
visits (≥1, past 12m) 
(n=513) 28.7% 36.7% 27.3% 0.10 
Participation to education 
classes (at least once) 
(n=506) 32.8% 51.3% 29.2% <0.001 
      
 
Quality of care indicators 
  
Participants 
forgoing 
care 
 
 
Participants 
not forgoing 
care 
 
     
    
 
OR (95%CI) 
 
Processes-of-care 
    
Annual HbA1c check ** (n=273) 98.0% 99.1% 0.4 (0.04;5.0) 
Eye examination by 
ophthalmologist †† 
(n=489) 81.8% 75.2% 1.5 (0.8;2.8) 
Annual urine test for 
microalbuminuria 
(n=425) 74.6% 73.4% 1.1 (0.6;1.9) 
Annual foot examination (n=494) 64.9% 68.1% 0.9 (0.5;1.4) 
Annual lipid profile (n=486) 96.1% 96.6% 0.9 (0.2;3.1) 
Seasonal influenza 
immunization 
(n=497) 70.1% 62.6% 1.4 (0.8;2.4) 
Home glucose monitoring (n=497) 86.8% 80.5% 1.6 (0.8;3.2) 
HbA1c knowledge (yes)  (n=433) 70.4% 62.4% 1.4 (0.8;2.5)  
     
    Difference (95%CI) 
Outcomes of care     
Mean HbA1c level, mean ** (n=172) 7.8 7.3 - 0.5 (- 1.1;0.03) 
Quality of life (health-related):     
  SF-12 PCS, mean (SD) (n=484) 39.0 44.3 5.3 (2.6;7.9) 
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  SF-12 MCS, mean (SD) (n=483) 39.0 48.4 9.5 (6.9;12.1) 
  ADDQoL, mean (SD) (n=497) -2.3 -1.4 0.9 (0.5;1.3) 
PACIC, mean (SD) (n=489) 2.9 2.7 - 0.1 (- 0.4;0.1) 
Care satisfaction (excellent-
very good) ¶ 
(n=494) 55.1% 69.2% 0.5 (0.3;0.9)  
     
 
*: Out of 519 CoDiab-VD cohort participants, 16 did not answer the forgoing care question 
 
† sum of complications among the following: ischemic heart diseases, stroke, retinopathy, chronic kidney 
disease (CKD) without dialysis, CKD with dialysis or kidney transplant, neuropathies, foot ulcer, lower 
limb amputation, severe hypo- or hyperglycemia 
 
 
** among participants reporting knowing what HbA1c is; ††: within two years; ¶ odd ratio 
 
Abbreviations: SF-12: Short Form-12; PCS: physical component score (mean 50 and SD 10 for American 
general population); MCS: mental component score (mean 50 and SD 10 for American general 
population); ADDQoL: Audit of Diabetes-Dependent Quality of Life 19 (score range: -9 (worse) to +3 
(best); PACIC: Patient Assessment of Chronic Illness Care (score 1 (never) to 5 (always)) 
 
 
 
